نتایج جستجو برای: relapsed hodgkin lymphoma

تعداد نتایج: 117560  

Armita Esmaili, Hamid Tabrizchee

  Background and Objectives: Classic Hodgkin lymphoma (CHL), anaplastic large cell lymphoma (ALCL) and some cases of diffuse large B cell lymphoma (DLBCL) have overlapping morphologic features. Since they all represent distinct clinico-pathologic entities, we explored the differential diagnostic impact of immunophenotyping to discriminate between them. Materials and Methods:...

Journal: :Oncology 2013
Loretta J Nastoupil Jean L Koff Christopher R Flowers

Mantle cell lymphoma (MCL) is a distinct subtype of non-Hodgkin lymphoma that has been associated with a poor prognosis. Despite improvements in frontline management strategies, including the incorporation of cytarabine, intensification of chemotherapeutic regimens, and consolidation with transplant, MCL remains incurable. Our current understanding of MCL biology affords the opportunity to inve...

Journal: :Journal of the National Comprehensive Cancer Network 2017

Journal: :Cancer control : journal of the Moffitt Cancer Center 2012
Michael Tomblyn

BACKGROUND Radioimmunotherapy (RIT) is a safe and effective therapeutic option for patients with indolent B-cell non-Hodgkin lymphomas (NHL), in both up-front and relapsed/refractory settings. Two approved agents (90Y-ibritumomab tiuxetan and 131I-tositumomab) are available in the United States. Both target CD20 with similar clinical outcomes but with unique clinical considerations and radiatio...

Journal: :Haematologica 2016
Aurore Perrot Hélène Monjanel Réda Bouabdallah Philippe Quittet Clémentine Sarkozy Marc Bernard Aspasia Stamatoullas Cécile Borel Krimo Bouabdallah Emmanuelle Nicolas-Virelizier Marion Fournier Franck Morschhauser Pauline Brice

Brentuximab vedotin was reported to be effective and safe against refractory/relapsed Hodgkin lymphoma in cohorts of between 12 to 102 patients. Herein we report our retrospective analysis of the French experience with brentuximab vedotin used alone to treat 240 refractory/relapsed Hodgkin lymphoma patients enrolled in a named patient program between 2011 and 2013. All patients had histological...

Journal: :iranian journal of blood and cancer 0
soheila zareifar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) babak abdolkarimi assistant professor of pediatric hematology-oncology, lorestan university of medical sciences, khoramabad, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی لرستان (lorestan university of medical sciences) mohamadreza bordbar associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) mehran karimi professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) fazl saleh fellowship of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences) omidreza zekavat associate professor of pediatric hematology-oncology, department of pediatrics, shiraz university of medical sciences, shiraz, iranسازمان اصلی تایید شده: دانشگاه علوم پزشکی شیراز (shiraz university of medical sciences)

background: burkitt lymphoma is a common subtype of non-hodgkin lymphoma in children. it has a rapid and aggressive clinical course with frequent involvement of bone marrow and central nervous system. systemic chemotherapy is the mainstay of the treatment for this malignancy in children. in this systematic review, we discuss autologous and allogeneic hematopoietic stem cell transplantation (hsc...

2017
Jose D Sandoval-Sus Francis Mogollon-Duffo Ankita Patel Nathan Visweshwar Damian A Laber Richard Kim Michael V Jagal

BACKGROUND We report the first case to our knowledge of a patient with relapsed/refractory classical hodgkin lymphoma and liver failure with encephalopathy along with human immunodeficiency virus/acquired immunodeficiency syndrome infection, successfully treated with nivolumab without major side effects and encouraging prolonged disease control. CASE PRESENTATION In December 2015, at the time...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید